Previous studies have shown that the levels of CTGF expression in biological samples were increased in accordance with progression of human fibrotic diseases such as idiopathic pulmonary fibrosis and chronic kidney disease14, 15. The gene discussed is CCN2; the disease is pulmonary fibrosis.